# Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

> **NCT04611061** · — · COMPLETED · sponsor: **Nearmedic Plus LLC** · enrollment: 204 (actual)

## Conditions studied

- Acute Upper Respiratory Tract Infection
- Influenza
- Respiratory Viral Infection

## Interventions

- **DRUG:** Kagocel
- **DRUG:** No one

## Key facts

- **NCT ID:** NCT04611061
- **Lead sponsor:** Nearmedic Plus LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-02
- **Primary completion:** 2017-12-13
- **Final completion:** 2018-06-14
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04611061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04611061, "Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04611061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*